Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US8946422B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8946422-B2 |
| Application number | US-201113279852-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 24, 2011 |
| Priority date | Jul 27, 2005 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides compound and salts of Formula I and II, disclosed herein, which includes compounds of Formula A and Formula B: Such compounds possess useful antimicrobial activity. The variables R 2 , R 3 , R 5 , R 6 , R 7 , and R 9 shown in Formula A and B are defined herein. Certain compounds of Formula I and Formula II disclosed herein are potent and/or selective inhibitors of bacterial DNA synthesis and bacterial replication. The invention also provides antimicrobial compositions, including pharmaceutical compositions, containing one or more compounds of Formula I or Formula II and one or more carriers, excipients, or diluents. Such compositions may contain a compound of Formula I or Formula II as the only active agent or may contain a combination of a compound of Formula I or Formula II and one or more other active agents. The invention also provides methods for treating microbial infections in animals.
Opening claim text (preview).
What is claimed is: 1. A compound or salt thereof wherein the compound is (R)-7-(3-(2-aminopropan-2-yl)pyrrolidin-1-yl)-9-ethyl-6-fluoro-8-methoxyisothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione; or 9-ethyl-6-fluoro-8-methoxy-7-(piperazin-1-yl)isothiazolo[5,4-b]quinoline-3,4(2H,9H)-dione. 2. A pharmaceutical composition comprising a compound or salt of claim 1 , together with a pharmaceutically acceptable carrier, diluent, or excipient. 3.…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.